Cover image of DTB podcast
(2)
Health & Fitness
Medicine
Science

DTB podcast

Updated 4 days ago

Health & Fitness
Medicine
Science
Read more

For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Read more

For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

iTunes Ratings

2 Ratings
Average Ratings
1
1
0
0
0

iTunes Ratings

2 Ratings
Average Ratings
1
1
0
0
0

Listen to:

Cover image of DTB podcast

DTB podcast

Updated 4 days ago

Read more

For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Rank #1: June 2019: If the drugs don’t work

Podcast cover
Read more
In June's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) consider the European Medicines Agency's decision to amend the licence for omega-3 fatty acid medicines so that they will no longer be authorised for secondary prevention after myocardial infarction. The editors also review ospemifene, a new medicine for the management of vulvar and vaginal atrophy and discuss a case of delusional infestation in the treatment of ADHD with atomoxetine.

Read the full issue: https://dtb.bmj.com/content/57/6.

May 29 2019

9mins

Play

Rank #2: May 2019: The new GP contract - an opportunity for drugs and therapeutics

Podcast cover
Read more
In May's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the opportunities for drugs and therapeutics in the new GP contract for England. The editors also talk about the management of chronic cough and discuss a case of acute liver failure associated with a short course of nitrofuantoin.

Read the issue online: https://dtb.bmj.com/content/57/5.

May 15 2019

8mins

Play

Rank #3: April 2019: DOAC dosing in renal impairment

Podcast cover
Read more
In April's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the challenges of prescribing direct acting oral anticoagulant (DOAC) drugs for people with renal impairment. The editors also talk about the use of saline nasal irrigation and discuss central sensitisation syndrome.

Read the issue online: https://dtb.bmj.com/content/57/4.

Mar 20 2019

10mins

Play

Rank #4: March 2019: A new direction for diabetes

Podcast cover
Read more
In March's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) get excited about the impact that the results of the Direct study could have on the management of type 2 diabetes. The editors also discuss the combination of doxylamine and pyridoxine for the treatment of nausea and vomiting in pregnancy and consider the role of primary care in supporting patients who are taking clozapine.

Read the full issue: https://dtb.bmj.com/content/57/3.

Feb 25 2019

13mins

Play

Rank #5: February 2019: The past, present and future of inhaled corticosteroids for COPD

Podcast cover
Read more
In February's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of inhaled corticosteroids in the management of COPD (https://dtb.bmj.com/content/57/2/18). The editors also consider subclinical hypothyroidism in pregnancy (https://dtb.bmj.com/content/57/2/22) and discuss Gilbert’s syndrome (https://dtb.bmj.com/content/57/2/27).

Read the full issue: https://dtb.bmj.com/content/57/2

Jan 21 2019

8mins

Play

Rank #6: January 2019: Challenging the supremacy of intravenous antibiotics

Podcast cover
Read more
In January's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss whether intravenous antibiotics are always needed. The editors also consider the challenge of stopping antipsychotic drug treatment in people with intellectual disability and review a case of angioedema of the small bowel caused by lisinopril.

Read the issue: dtb.bmj.com/content/57/1.

Dec 14 2018

9mins

Play

Rank #7: December 2018: Information on medicines for patients

Podcast cover
Read more
In December's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the conditional authorisation process for medicines and the need for clearer labelling of medicines that have been through this approval processes. The editors also consider common sources of information on medicines for patients and review a case of interstitial lung disease associated with adalimumab.

Read the issue: https://dtb.bmj.com/content/56/12.

Nov 16 2018

7mins

Play

Rank #8: October 2018: atrial fibrillation, opioids for chronic pain and over-the-counter sildenafil

Podcast cover
Read more
In October's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the place of population screening for atrial fibrillation and the need for more evidence to support a change in national policy (https://dtb.bmj.com/content/56/10/112).
The editors also consider problems associated with long-term opioid use in the management of chronic pain (https://dtb.bmj.com/content/56/10/118). Please watch the video about Michael's moving story on this subject at dtb.bmj.com.
The launch of slidenafil as an over-the-counter pharmacy medicine (https://dtb.bmj.com/content/56/10/123) is also discussed.

Read the latest from the reinvented Drug and Therapeutics Bulletin here: dtb.bmj.com.

Oct 08 2018

10mins

Play

Rank #9: Here's your New DTB!

Podcast cover
Read more
In September's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) highlight some of the changes to DTB that have taken place this month and discuss the background and rationale to these changes. Read this month's editorial: https://dtb.bmj.com/content/56/9/98.
The editors also consider the place for monitored dosage systems (https://dtb.bmj.com/content/56/9/102) and discuss the evidence for using labetalol as a first-line treatment option for hypertension in pregnancy (https://dtb.bmj.com/content/56/9/107).

Meet the new DTB here: https://dtb.bmj.com/content/56/9.

Sep 12 2018

8mins

Play

Rank #10: August 2018: what’s your position on giving birth?

Podcast cover
Read more
In the August's podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the results of an awarding research paper that assessed the impact of spending the second stage of labour either in a recumbent or upright position.
Read the editorial: https://dtb.bmj.com/content/56/8/85.

The editors also consider nutritional support in primary care (https://dtb.bmj.com/content/56/8/90) and discuss new licensing pathways that provide faster access to medicines (https://dtb.bmj.com/content/56/8/93).

Aug 06 2018

11mins

Play

Rank #11: July 2018: managing herbal-drug interactions

Podcast cover
Read more
In July’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the risk of drug interactions with herbal medicines.
Read the editorial: https://dtb.bmj.com/content/56/7/73.

The editors also review the evidence for ocrelizumab for relapsing MS and early primary progressive MS (https://dtb.bmj.com/content/56/7/80), and discuss the role of metformin in people with type 1 diabetes (https://dtb.bmj.com/content/56/7/78).

Jul 11 2018

13mins

Play

Rank #12: June 2018: Antidepressants - there is no news

Podcast cover
Read more
In the June’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss whether a recently published large meta-analysis on the effectiveness of antidepressants tells us anything new. Read the editorial here: dtb.bmj.com/content/56/6/61.

The editors also review the evidence for the combination analgesic of tramadol/dexketoprofen (dtb.bmj.com/content/56/6/66), and question the dose of paracetamol for older people (dtb.bmj.com/content/56/6/69).

Jul 02 2018

10mins

Play

Rank #13: May 2018: Does pulmonary rehabilitation need more PR?

Podcast cover
Read more
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the evidence for pulmonary rehabilitation for COPD and highlight the need for more publicity for its benefits. Read the editorial here: http://dtb.bmj.com/content/56/5/49.

The editors also review the evidence for safinamide for Parkinson’s disease (http://dtb.bmj.com/content/56/5/54), and discuss the use of bezlotoxumab, a monoclonal antibody licensed for the prevention of recurrence of Clostridium difficile infection in adults who are at high risk of recurrence (http://dtb.bmj.com/content/56/5/57).

May 09 2018

11mins

Play

Rank #14: April 2018: STOMP - time to make more noise

Podcast cover
Read more
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss a national campaign in England that is tackling the inappropriate use of antipsychotic and antidepressant medicines in people with learning or intellectual disability.
Read the article: http://dtb.bmj.com/content/56/4/37.

The editors also review the evidence for a once-daily triple inhaler for maintenance treatment for adults with moderate to severe COPD (http://dtb.bmj.com/content/56/4/42), and discuss off-label use of high-dose antihistamines for chronic spontaneous urticaria in adults (http://dtb.bmj.com/content/56/4/45).

Apr 11 2018

15mins

Play

Rank #15: March 2018: Do hypertension guidelines put the person first?

Podcast cover
Read more
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss some of the difficulties in implementing clinical guidelines for the management of elevated blood pressure and the potential impact of changes in the threshold for a diagnosis of hypertension (http://dtb.bmj.com/content/56/3/25).
The editors also review the evidence for dupliumab for the treatment of moderate-to-severe atopic dermatitis in adults (http://dtb.bmj.com/content/56/3/30) and discuss drug names (http://dtb.bmj.com/content/56/3/33).

Read the full March 2018 issue here: http://dtb.bmj.com/content/56/3.

Mar 12 2018

11mins

Play

Rank #16: February 2018: Clinical guidelines - more PDAs please

Podcast cover
Read more
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the importance of developing patient decision aids to support the implementation of clinical guidelines (http://dtb.bmj.com/content/56/2/13).

The editors also review the evidence for cladribine for the treatment of highly active relapsing multiple sclerosis (http://dtb.bmj.com/content/56/2/21) and discuss the latest levonorgestrel IUS device to be marketed for contraception (http://dtb.bmj.com/content/56/2/18).

Feb 09 2018

13mins

Play

Rank #17: January 2018: No alchemy for obesity

Podcast cover
Read more
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the importance of exercise, diet and behaviour modification in the management of obesity and consider the limitations of anti-obesity drugs. http://dtb.bmj.com/content/56/1/1

The editors also review the evidence for ▼patiromer, a cation exchange polymer, that has recently been marketed for the management of hyperkalaemia - http://dtb.bmj.com/content/56/1/6 and discuss the management of gout. http://dtb.bmj.com/content/56/1/9

Jan 02 2018

12mins

Play

Rank #18: September 2017: Vitamin D and adolescents: a forgotten ‘at risk’ group?

Podcast cover
Read more
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss vitamin D deficiency in teenagers and highlight the challenge of implementing national recommendations on vitamin D intake in young people. Full article here: http://dtb.bmj.com/content/55/9/1.

The editors also review the management of scarlet fever (http://dtb.bmj.com/content/55/9/102.2) and consider two drugs (baricitinib and tofacitinib) recently licensed for the management of rheumatoid arthritis (http://dtb.bmj.com/content/55/9/102.1).

Sep 04 2017

11mins

Play

Rank #19: June 2017: Turning the tide of high-dose inhaled corticosteroids

Podcast cover
Read more
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of high-dose inhaled corticosteroids in asthma and COPD.

The editors also highlight some of the challenges associated with the management of superficial venous thrombosis of the leg and discuss the use of carbohydrate deficient transferrin as a biomarker for the assessment of chronic alcohol use.

Read more about the DTB's June 2017 issue: http://dtb.bmj.com/content/55/6#DTBSelect.
Editorial: http://dtb.bmj.com/content/55/6/61.

Related articles: http://dtb.bmj.com/content/55/6/66 and http://dtb.bmj.com/content/55/6/69.

Jun 05 2017

11mins

Play

Rank #20: May 2017: Rational rationing in the NHS?

Podcast cover
Read more
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss attempts by the NHS in England to target £400m of prescribing expenditure that is reported to be wasted on a range of products that are considered to be of low value. Editorial available here: http://dtb.bmj.com/content/55/5/49

The editors also review the evidence for the use of off-label testosterone supplementation in menopausal women (http://dtb.bmj.com/content/55/5/57) and discuss a new formulation of the topical antiseptic dequalinium (http://dtb.bmj.com/content/55/5/54) that is licensed for treatment of bacterial vaginosis.

May 03 2017

13mins

Play